AmyT

Product Roundup: Continuous Monitors (in the Holding Pen), Convenience Enhancers

*ADA Conference News*
With over 150 companies going all out to showcase the latest and greatest here, I was surprised to hear many conference attendees expressing disappointment not to see anything “earth-shattering” on the new technology front this year. Nevertheless, three continuous monitoring products, currently in the holding pen awaiting FDA approval, look promising:
* DexCom was showing off its new Continuous Monitor, featuring a long-term implantable sensor half the size of a triple-A battery,…

Read more »

Jim Turner, Party Animal

*Still live from the ADA Conference in San Diego*
To pick up where I left off, the dLife cocktail party last night was a blast. They premiered the new season of shows, which looks to be getting better all the time. The new idea is to do a “group intro,” and then split up the hosts, so that each has a chance to shine with his or her guest. A welcome improvement, I’m sure you’d…

Read more »

Learning Lots… and My Day with Mother Love

*Reporting live from the annual ADA Conference in San Diego*
Due to some official scheduling changes and my own fickle interests, Day 1 turned out quite a bit different than planned. This morning I sat in on a session about how healthcare providers can use the National Diabetes Education Program to help their patients improve BG control. This was particularly interesting since the audience was mostly doctors and educators, and the slant was “how to…

Read more »

LIVE from the Biggest Event in Diabetes

The whole thing was so last-minute, I barely got my insulin packs cooled, but here I am — LIVE! — at the center of the American Diabetes universe: The American Diabetes Association’s Annual “Scientific Sessions” conference in San Diego, CA. I bet lots of you don’t know much about this event. Actually, neither did I until a few weeks ago. Then I was hemming and hawing about attending, thinking it logistically impossible with my mega-busy…

Read more »

Monster Campaign & the ADA’s Big Conference

To promote the new diabetes drug Byetta (aka Exenatide injection), Eli Lilly & Co. and partner Amylin Pharmaceuticals are featuring this guy, the Gila monster, during TV interviews today with the drug’s discoverer and a diabetes doctor. The drug is of course the one derived from the saliva of this venomous lizard.
Byetta seems to have exciting possiblities to increase insulin secretion in Type 2 diabetics, but once again, you will find most press coverage…

Read more »